The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Emergence of Coagulase-Negative Staphylococci as a Cause of Native Valve Endocarditis
Abstract
BACKGROUND: Coagulase-negative staphylococci (CoNS) are an infrequent cause of native valve endocarditis (NVE), and our understanding of NVE caused by CoNS is incomplete. METHOD: The International Collaboration on Endocarditis-Prospective Cohort Study includes patients with endocarditis from 61 centers in 28 countries. Patients with definite cases of NVE caused by CoNS who were enrolled during the period June 2000-August 2006 were compared with patients with definite cases of NVE caused by Staphylococcus aureus and patients with NVE caused by viridans group streptococci. Multivariable logistic regression was used to determine factors associated with death in patients with NVE caused by CoNS. RESULTS: Of 1635 patients with definite NVE and no history of injection drug use, 128 (7.8%) had NVE due to CoNS. Health care-associated infection occurred in 63 patients (49%) with NVE caused by CoNS. Comorbidities, long-term intravascular catheter use, and history of recent invasive procedures were similar among patients with NVE caused by CoNS and among patients with NVE caused by S. aureus. Surgical treatment for endocarditis occurred more frequently in patients with NVE due to CoNS (76 patients [60%]) than in patients with NVE due to S. aureus (150 [33%]; P=.01) or in patients with NVE due to viridans group streptococci (149 [44%]; P=.01). Despite the high rate of surgical procedures among patients with NVE due to CoNS, the mortality rates among patients with NVE due to CoNS and among patients with NVE due to S. aureus were similar (32 patients [25%] and 124 patients [27%], respectively; P=.44); the mortality rate among patients with NVE due to CoNS was higher than that among patients with NVE due to viridans group streptococci (24 [7.0%]; P=.01). Persistent bacteremia (odds ratio, 2.65; 95% confidence interval, 1.08-6.51), congestive heart failure (odds ratio, 3.35; 95% confidence interval, 1.57-7.12), and chronic illness (odds ratio, 2.86; 95% confidence interval, 1.34-6.06) were independently associated with death in patients with NVE due to CoNS (c index, 0.73). CONCLUSIONS: CoNS have emerged as an important cause of NVE in both community and health care settings. Despite high rates of surgical therapy, NVE caused by CoNS is associated with poor outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Of interest, data suggest that the overall outcomes for patients with CoNS IE and S aureus IE are similar.137”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027
Self-citationDurack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Rao, S. V., & Jollis, J. G. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.10.991 · Cited by 2,243
Friedman, N., Kaye, K., Stout, J., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J. K., Walton, A., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,593
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174
Self-citationPathogenesis of infections due to coagulasenegative staphylococci
von Eiff, C., Peters, G., & Heilmann, C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00438-3 · Cited by 1,041
Gill, S. R., Fouts, D. E., Archer, G. L., Mongodin, E. F., DeBoy, R. T., Ravel, J., Paulsen, I. T., Kolonay, J. F., Brinkac, L. M., Beanan, M., et al. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2426-2438.2005 · Cited by 1,026
The staphylococci in human disease
Crossley, K., & Archer, G. L. (1996) · Churchill Livingstone eBooks · Cited by 625
Systemic Infection Related to Endocarditis on Pacemaker Leads: Clinical Presentation and Management
Klug, D., Lacroix, D., Savoye, C., Goullard, L., Grandmougin, D., Hennequin, J. L., Kacet, S., & Lekieffre, J. (1997) · Circulation · doi:10.1161/01.cir.95.8.2098 · Cited by 593
Journal of Heart Valve Disease
Reul, H. (2024) · Journal of Heart Valve Disease · doi:10.47310/jhvd · Cited by 540
Research works printed but not linked: 2
- 1963, Antimicrobial Agents and Chemotherapy, 161, 635
- FINLAND, 1970, Annals of Internal Medicine, 72, 341, 10.1059/0003-4819-72-3-341 · DOI
Cited by
Sorted by citations
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Self-citationGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Self-citationCoagulase-Negative Staphylococci
Becker, K., Heilmann, C., & Peters, G. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-13 · Cited by 1,742
Cahill, T. J., & Prendergast, B. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00067-7 · Cited by 1,095
Challenges in Infective Endocarditis
Cahill, T. J., Baddour, L. M., Habib, G., Hoen, B., Salaün, E., Pettersson, G., Schäfers, H., & Prendergast, B. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.066 · Cited by 724
Self-citationCoagulase-Negative Staphylococcal Infections
Rogers, K. L., Fey, P. D., & Rupp, M. E. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.10.001 · Cited by 417
Population-Based Epidemiology and Microbiology of Community-Onset Bloodstream Infections
Laupland, K. B., & Church, D. L. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-14 · Cited by 321
Lalani, T., Cabell, C. H., Benjamin, D. K., Lasca, O., Naber, C., Fowler, V. G., Corey, G. R., Chu, V. H., Fenely, M., Pachirat, O., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.864488 · Cited by 308
Self-citationAre coagulase-negative staphylococci virulent?
Heilmann, C., Ziebuhr, W., & Becker, K. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.11.012 · Cited by 325
Health Care–Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
Benito, N., Miró, J. M., de Lazzari, E., Cabell, C. H., del Río, A., Altclas, J., Commerford, P., Delahaye, F., Dragulescu, S., Giamarellou, H., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00004 · Cited by 277
Self-citationKiefer, T., Park, L., Tribouilloy, C., Cortes, C., Casillo, R., Chu, V., Delahaye, F., Durante-Mangoni, E., Edathodu, J., Falces, C., et al. (2011) · JAMA · doi:10.1001/jama.2011.1701 · Cited by 242
Self-citationJCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis
Nakatani, S., Ohara, T., Ashihara, K., Izumi, C., Iwanaga, S., Eishi, K., Okita, Y., Daimon, M., Kimura, T., Toyoda, Ḱ., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0549 · Cited by 181
Widerström, M., Wiström, J., Sjöstedt, A. B., & Monsen, T. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1270-6 · Cited by 170
Barbier, F., Ruppé, É., Hernández, D., Lebeaux, D., François, P., Félix, B., Desprez, A., Maïga, A., Woerther, P., Gaillard, K., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/653483 · Cited by 169
Seifert, H. (2009) · Clinical Infectious Diseases · doi:10.1086/598188 · Cited by 151
Endocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00082-5 · Cited by 144
Self-citationEpidemiological and resistance issues in multidrug-resistant staphylococci and enterococci
Leclercq, R. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02739.x · Cited by 140
Rohacek, M., Weisser, M., Kobza, R., Schoenenberger, A. W., Pfyffer, G. E., Frei, R., Erné, P., & Trampuž, A. (2010) · Circulation · doi:10.1161/circulationaha.109.906461 · Cited by 127
Staphylococcus epidermidis and Other Coagulase-Negative Staphylococci
Rupp, M. E., & Fey, P. D. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00197-1 · Cited by 118
Chu, V. H., Miro, J. M., Hoen, B., Cabell, C. H., Pappas, P. A., Jones, P., Stryjewski, M. E., Anguera, I., Braun, S., Muñoz, P., et al. (2009) · Heart · doi:10.1136/hrt.2008.152975 · Cited by 109
Self-citationBarbier, F., Lebeaux, D., Hernández, D., Delannoy, A., Caro, V., François, P., Schrenzel, J., Ruppé, É., Gaillard, K., Wolff, M., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq410 · Cited by 101
Infective Endocarditis: The European Viewpoint
Tornos, P., González‐Alujas, T., Thuny, F., & Habib, G. (2011) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2011.03.004 · Cited by 91
Self-citationArgemi, X., Riegel, P., Lavigne, T., Lefèbvre, N., Grandpré, N., Hansmann, Y., Jaulhac, B., Prévost, G., & Schramm, F. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00177-15 · Cited by 76
Clinical Outcome After a Totally Implantable Venous Access Port-Related Infection in Cancer Patients
Lebeaux, D., Larroque, B., Gellen‐Dautremer, J., Leflon‐Guibout, V., Dreyer, C., Bialek-Davenet, S., Froissart, A., Hentic, O., Tessier, C., Ruimy, R., et al. (2012) · Medicine · doi:10.1097/md.0b013e318275ffe1 · Cited by 76
Surveillance and management of multidrug-resistant microorganisms
Orsi, G. B., Falcone, M., & Venditti, M. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.77 · Cited by 69
García-de-la-Mària, C., Marco, F., Armero, Y., Soy, D., Moreno, A., del Rı́o, A., Almela, M., Cervera, C., Ninot, S. P. I., Falces, C., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-09 · Cited by 68
Self-citationVirulence factors associated with Coagulase Negative Staphylococci isolated from human infections
Soumya, K. R., Philip, S., Sugathan, S., Mathew, J., & Radhakrishnan, E. K. (2017) · 3 Biotech · doi:10.1007/s13205-017-0753-2 · Cited by 67
Infective Endocarditis in High-Income Countries
Nappi, F., Martuscelli, G., Bellomo, F., Singh, S. S. A., & Moon, M. R. (2022) · Metabolites · doi:10.3390/metabo12080682 · Cited by 68
Spanu, T., Carolis, E. D., Fiori, B., Sanguinetti, M., D’Inzeo, T., Fadda, G., & Posteraro, B. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03181.x · Cited by 64
Wojtyczka, R. D., Kępa, M., Idzik, D., Kubina, R., Kabała‐Dzik, A., Dziedzic, A. M., & Wąsik, T. J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/590703 · Cited by 64
Siciliano, V., Passerotto, R. A., Chiuchiarelli, M., Leanza, G. M., & Ojetti, V. (2023) · Life · doi:10.3390/life13051126 · Cited by 58
Yavuz, S. Ş., Şensoy, A., Kaşıkçıoğlu, H., Çeken, S., Deniz, D., Yavuz, A., Koçak, F., Midilli, K., Eren, M., & Yekeler, İ. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.11.007 · Cited by 54
Widerström, M., Monsen, T., Karlsson, C., Edebro, H., Johansson, A. F., & Wiström, J. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540903146987 · Cited by 49
Clinical Characteristics of Infections in Humans Due to Staphylococcus epidermidis
Rupp, M. E. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-736-5_1 · Cited by 46
Staphylococcus epidermidis in Biomaterial-Associated Infections
Mack, D., Davies, A. P., Harris, L. G., Jeeves, R. E., Pascoe, B., Knobloch, J. K. ‐., Rohde, H., & Wilkinson, T. S. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1031-7_2 · Cited by 47
Ružauskas, M., Šiugždinienė, R., Klimienė, I., Virgailis, M., Mockeliūnas, R., Vaškevičiūtė, L., & Zienius, D. (2014) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-014-0056-y · Cited by 42
Lebeaux, D., Barbier, F., Angebault, C., Benmahdi, L., Ruppé, É., Félix, B., Gaillard, K., Djossou, F., Epelboin, L., Dupont, C., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00547-11 · Cited by 41
Infectious endocarditis: An update for emergency clinicians
Long, B., & Koyfman, A. (2018) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2018.06.074 · Cited by 44
Cave, R. J., Misra, R., Chen, J., Wang, S., & Mkrtchyan, H. V. (2019) · Scientific Reports · doi:10.1038/s41598-019-45886-6 · Cited by 39
A review of current treatment strategies for infective endocarditis
Paz, D. L., Lakbar, I., & Tattevin, P. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1822165 · Cited by 39
Molina, J., Peñuela, I., Lepe, J. A., Gutiérrez-Pizarraya, A., Gómez, M. J., García-Cabrera, E., Cordero, E., Aznar, J., & Pachón, J. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.10.021 · Cited by 37
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement
Panagides, V., del Val, D., Abdel‐Wahab, M., Mangner, N., Durand, É., Ihlemann, N., Ureña, M., Pellegrini, C., Giannini, F., Gąsior, T., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab1004 · Cited by 37
Infective endocarditis and diabetes mellitus: Results from a single-center study from 1994 to 2017
Benvenga, R. M., Rosa, R. D., Silverio, A., Matturro, R., Zambrano, C. M., Masullo, A., Mastrogiovanni, G., Soriente, L., Ascoli, R., Citro, R., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223710 · Cited by 34
Monk, A. B., Boundy, S., Chu, V. H. Y., Bettinger, J. C., Robles, J. R., Fowler, V. G., & Archer, G. L. (2008) · Infection and Immunity · doi:10.1128/iai.00606-08 · Cited by 34
Self-citationClinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci
Cervera, C., Castañeda, X., Pericàs, J. M., del Rı́o, A., de la Mària, C. G., Mestres, C. A., Falces, C., Marco, F., Moreno, A., & Miró, J. M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.038 · Cited by 33
Self-citationCurrent management of bloodstream infections
Rodríguez‐Baño, J., de Cueto, M., Retamar, P., & Gálvez-Acebal, J. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.49 · Cited by 33
Improved multiplex PCR primers for rapid identification of coagulase-negative staphylococci
Kim, J.-U., Hong, J., Lim, J.-A., Heu, S., & Roh, E. (2017) · Archives of Microbiology · doi:10.1007/s00203-017-1415-9 · Cited by 32
Host–Bacterium Interaction Mechanisms in Staphylococcus aureus Endocarditis: A Systematic Review
Nappi, F., & Singh, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311068 · Cited by 32
Infective Endocarditis in the Elderly: Diagnostic and Treatment Options
Ursi, M. P., Durante‐Mangoni, E., Rajani, R., Hancock, J., Chambers, J. B., & Prendergast, B. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0614-7 · Cited by 29
Native valve Staphylococcus capitis infective endocarditis: a mini review
AlHennawi, H. T., Mahdi, E., & Memish, Z. A. (2019) · Infection · doi:10.1007/s15010-019-01311-8 · Cited by 28
Short-course therapy for bloodstream infections in immunocompetent adults
Corey, G. R., Stryjewski, M. E., & Everts, R. J. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70567-9 · Cited by 28
Self-citationEndocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00077-1 · Cited by 28
Self-citationBenedetto, U., Spadaccio, C., Gentile, F., Moon, M. R., & Nappi, F. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3880 · Cited by 26
Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73131-8 · Cited by 25
Self-citationde la Mària, C. G., Cervera, C., Pericàs, J. M., Castañeda, X., Armero, Y., Soy, D., Almela, M., Ninot, S. P. I., Falces, C., Mestres, C. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125818 · Cited by 25
Self-citationWiderström, M., Wiström, J., Ek, E., Edebro, H., & Monsen, T. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02757.x · Cited by 25
Diseases of the Cardiovascular System
Lockhart, P. B., & Sun, Y. (2021) · Wiley eBooks · doi:10.1002/9781119597797.ch14 · Cited by 27
Sex Differences in Infective Endocarditis
Polishchuk, I., Stavi, V., Awesat, J., Golan, Y. B.-B., Bartal, C., Sagy, I., Jotkowitz, A., & Barski, L. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.08.021 · Cited by 23
Munier, A., LASTOURS, V. D., Barbier, F., Chau, F., Fantin, B., & Ruimy, R. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.09.004 · Cited by 23
An Unusual Presentation of Native Valve Endocarditis Caused by Staphylococcus warneri
Bhardwaj, B., Bhatnagar, U. B., & Conaway, D. G. (2016) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0823 · Cited by 22
Infective Endocarditis in the Intensive Care Unit
Keynan, Y., Singal, R. K., Kumar, K., Arora, R. C., & Rubinstein, E. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.06.011 · Cited by 23
Trifunović, D., Vujisic-Tesic, B. D., Obrenović-Kirćanski, B., Ivanovic, B. A., Kalimanovska‐Oštrić, D., Petrović, M., Boricic-Kostic, M., Matic, S., Stevanović, G., Marinković, J., et al. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.08.010 · Cited by 21
Morioka, S., Ichikawa, M., Mori, K. P., & Kurai, H. (2018) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2018.1451917 · Cited by 21
Mencacci, A., Leli, C., Montagna, P., Cardaccia, A., Meucci, M., Bietolini, C., Cenci, E., Pasticci, M. B., & Bistoni, F. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.040113-0 · Cited by 20
Hetem, D. J., Rooijakkers, S. H. M., & Ekkelenkamp, M. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00176-3 · Cited by 23
Nappi, F., Iervolino, A., & Singh, S. S. A. (2021) · BioMed Research International · doi:10.1155/2021/7302165 · Cited by 18
Treatment strategies for infective endocarditis
Chopra, T., & Kaatz, G. W. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903496430 · Cited by 18
The strategy of antibiotic use in critically ill neutropenic patients
Legrand, M. M., Max, A., Schlemmer, B., Azoulay, É., & Gachot, B. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-22 · Cited by 17
A Contemporary Picture of Coagulase-Negative Staphylococcal Endocarditis
Palom-Grau, C., Cuervo, G., Muñóz, P., Arriaza, M. M., Martínez‐Sellés, M., Ramallo, V. J. G., de Alarcón, A., Borrego, M. P., Rodríguez-García, R., Esteban, Á. R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.09.027 · Cited by 18
Commensal Microbiota Contributes to Chronic Endocarditis in TAX1BP1 Deficient Mice
Nakano, S., Ikebe, E., Tsukamoto, Y., Wang, Y., Matsumoto, T., Mitsui, T., Yahiro, T., Inoue, K., Kawazato, H., Yasuda, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073205 · Cited by 18
Tashiro, M., Izumikawa, K., Ashizawa, N., Narukawa, M., & Yamamoto, Y. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.09.019 · Cited by 17
Risk of endocarditis among patients with coagulase-negative Staphylococcus bacteremia
Ramos, A., González-Merino, P., Martin, E. S., de la Fuente, M. M., López, G. E., Eisenhofer, A. A., Expósito-Palomo, E., Gutiérrez‐Villanueva, A., Diego‐Yagüe, I., Múñez, E., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-41888-7 · Cited by 16
Duah, M. (2010) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-9-9 · Cited by 16
Prevalence of Bacteria in the Circulation of Cardiovascular Disease Patients, Madurai, India
Dinakaran, V., John, L., Rathinavel, A., Gunasekaran, P., & Rajendhran, J. (2012) · Heart Lung and Circulation · doi:10.1016/j.hlc.2012.02.007 · Cited by 16
Short-course therapy for severe infections
Rubinstein, E., & Keynan, Y. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.04.013 · Cited by 14
Causal Inference Regarding Infectious Aetiology of Chronic Conditions: A Systematic Review
Orrskog, S., Medin, E., Tsolova, S., & Semenza, J. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068861 · Cited by 14
Vasconcellos, D., Weng, B., Wu, P., Thompson, G., & Sutjita, M. (2022) · Case Reports in Infectious Diseases · doi:10.1155/2022/7183049 · Cited by 14
Magarifuchi, H., Kusaba, K., Yamakuchi, H., Hamada, Y., Urakami, T., & Aoki, Y. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.05.008 · Cited by 12
Tchana‐Sato, V., Hans, G. A., Frippiat, F., Zekhnini, I., Dulgheru, R., Lavigne, J. P., & Defraigne, J. O. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.09.010 · Cited by 12
Rasmussen, R. V., Snygg‐Martin, U., Olaison, L., Andersson, R., Buchholtz, K., Larsen, C. T., Hansen, T. F., Køber, L., Hassager, C., & Bruun, N. E. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540902896061 · Cited by 12
Leaky barriers to gene sharing between locally co-existing coagulase-negative Staphylococcus species
Ikhimiukor, O. O., Souza, S. S. R., Marcovici, M. M., Nye, G. J., Gibson, R. J., & Andam, C. P. (2023) · Communications Biology · doi:10.1038/s42003-023-04877-0 · Cited by 11
Staphylococcus epidermidis and Other Coagulase-Negative Staphylococci
Rupp, M. E., & Fey, P. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00196-x · Cited by 11
Kim, J. N., Kim, J. H., Lee, H. J., Lee, S. J., Lee, S. H., Lee, E. H., Baek, Y. J., Ahn, J. Y., Jeong, S. J., Ku, N. S., et al. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00642-8 · Cited by 10
Lazarevic, V., Gaïa, N., Pham, T., de Lorenzi-Tognon, M., Girard, M., Mauffrey, F., Charretier, Y., Renzi, G., Huber, C. H., & Schrenzel, J. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1532257 · Cited by 10
Alawad, M. J., Ali, G. A. M., & Goravey, W. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5591 · Cited by 13
Treatment of Gram-positive left-sided infective endocarditis with daptomycin
Kaya, S., Yılmaz, G., Kalkan, A., Ertunç, B., & Köksal, İ. (2013) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0546-9 · Cited by 10
Coagulase negative staphylococci - a fast emerging threat.
Latif, M., Usman, J., Gilani, M., Munir, T., Mushtaq, M., & Anjum, R. (2015) · PubMed · Cited by 10
Agarwal, L., Singh, A., Agarwal, A., & Agarwal, A. (2016) · Medical Journal of Dr D Y Patil University · doi:10.4103/0975-2870.186070 · Cited by 10
Ibrahim, Y. M., & El-Wafa, W. M. A. (2020) · Journal of Chemotherapy · doi:10.1080/1120009x.2020.1761638 · Cited by 10
Native Valve Endocarditis due to Staphylococcus warneri Developing in a Patient with Type 1 Diabetes
Yamamoto, J., Endo, A., Sugawara, H., Izumi, T., Takahashi, K., Yamamoto, S., Akiyama, M., Adachi, O., Kaneko, K., Sawada, S., et al. (2020) · Internal Medicine · doi:10.2169/internalmedicine.4661-20 · Cited by 10
Kim, J. N., Kim, J. H., Lee, H. J., Lee, S. J., Kim, C., Lee, J. A., Lee, S. H., Pyo, W. K., Ahn, J. Y., Jeong, S. J., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12010173 · Cited by 9
Successful management of a complicated clinical crisis
Xu, P., Zeng, H., Zhou, M., Ouyang, J., Chen, B., & Zhang, Q. (2017) · Medicine · doi:10.1097/md.0000000000009451 · Cited by 9
Schandiz, H., Hermansen, N. O., Jørgensen, T., & Roald, B. (2015) · Apmis · doi:10.1111/apm.12396 · Cited by 9
N’Guyen, Y., Baumard, S., Vernet-Garnier, V., Batalla, A. S., de Champs, C., Jaussaud, R., & Strady, C. (2011) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2011.617777 · Cited by 9
Elsherif, H. M., Helal, Z. H., El‐Ansary, M. R., Fahmy, Z. A., Eltayeb, W. N., Radwan, S., & Aboshanab, K. M. (2020) · BioMed Research International · doi:10.1155/2020/6981095 · Cited by 9
Infective endocarditis: Role of molecular techniques in early diagnosis
Albloshi, A. M. K., & Alqumber, M. A. A. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.07.060 · Cited by 10
Wheat, W., Simiyu, B., Andonie, G., & Bellfi, L. T. (2024) · Clinical Therapeutics · doi:10.1016/j.clinthera.2024.01.012 · Cited by 8
Native mitral valve infective endocarditis caused by Staphylococcus warneri : A case‐based review
Kurihara, I., Yoshida, K., Fukuchi, T., & Sugawara, H. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4476 · Cited by 8
Staphylococcus caprae native mitral valve infective endocarditis
Kwok, T. C., Poyner, J., Olson, E., Henriksen, P. A., & Koch, O. (2016) · JMM Case Reports · doi:10.1099/jmmcr.0.005065 · Cited by 7
Rapid Explantation of Rapid-Deployment Sutureless Valve in Case of Acute Endocarditis
Bacco, L. D., Pfeiffer, S., Fischlein, T. J. M., & Santarpino, G. (2017) · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery · doi:10.1097/imi.0000000000000427 · Cited by 7
Metadata
- Authors
- Chu, V. H., Woods, C. W., Miro, J. M., Hoen, B., Cabell, C. H., Pappas, P. A., Federspiel, J., Athan, E., Stryjewski, M. E., Nacinovich, F., Marco, F., Levine, D. P., Elliott, T. S., Fortes, C. Q., Tornos, P., Gordon, D. L., Utili, R., Delahaye, F., Corey, G. R., Fowler, V. G., & International Collaboration on Endocarditis-Prospective Cohort Study Group
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Hôpital Saint-Jacques (FR)
- Barwon Health (AU)
- Instituto Cardiovascular de Buenos Aires (AR)
- Universitat de Barcelona (ES)
- Wayne State University (US)
- Queen Elizabeth Hospital Birmingham (GB)
- Hospital Universitário Clementino Fraga Filho (BR)
- Vall d'Hebron Hospital Universitari (ES)
- University of Campania "Luigi Vanvitelli" (IT)
- Hôpital Louis Pradel (FR)
- Corresponding author
- Chu, V. H.
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-15
- Volume
- 46
- Issue
- 2
- Pages
- 232-242
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2152846901
- Semantic Scholar
- 5890d85407bf1bd730d39e425dfc5fb5da14b1b0
- Cited by
- 187
- References
- 28
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 12 · 2022: 10 · 2021: 12 · 2020: 13 · 2019: 8 · 2018: 8 · 2017: 11 · 2016: 8 · 2015: 13 · 2014: 6 · 2013: 11 · 2012: 9
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Deakin Research Online (Deakin University) (submittedVersion)
- Funders
- American Heart Association (0675027N)
- Generalitat de Catalunya
- National Institutes of Health
- Instituto de Salud Carlos III (RD06/0008)
- National Institute of Allergy and Infectious Diseases (R01AI068804)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- coagulase-negative staphylococci, native valve endocarditis, Staphylococcus aureus, Streptococcus viridans, endocarditis mortality, persistent bacteremia, congestive heart failure, nosocomial infections, surgical treatment, mortality risk factors, invasive procedures
- MeSH terms
- Adult, Aged, Coagulase, Cross Infection, Endocarditis, Bacterial, Female, Heart Failure, Heart Valve Diseases, Humans, Male, Middle Aged, Pacemaker, Artificial, Prospective Studies, Staphylococcus, Methicillin Resistance, Community-Acquired Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review